Inorganic Chemistry
Article
TMS) δ = 7.92 (2 H, d, 3J (H,H) = 7.8, Acenap 4,7-H), 7.75−7.66 (3
H, m, Se+Ph 13−15-H), 7.66−7.56 (3 H, m, Acenap 8-H, Se+Ph 12,16-
H), 7.40 (1 H, d, 3J (H,H) = 7.6, Acenap 3-H), 3.55−3.41 (4 H, m, 2
× CH2), 3.38 (3 H, s, 2J (H,Se) = 13.2, CH3). 77Se NMR (51.5 MHz,
CD3CN, 25 °C, Me2Se): δ = 420 (s). 19F NMR (376.5 MHz, CD3CN,
25 °C, CCl3F): −79.77(s). MS (ES+): m/z (%) 402.84 (100) [M+ −
OTf]. Anal. Calcd for C20H16BrF3O3SSe: C, 43.5; H, 2.9. Found: C,
43.1; H, 2.9.
analytically pure sample was obtained by recrystallization from
diffusion of hexane into a dichloromethane solution of the product
1
(0.34 g, 96%); mp 92−94 °C. H NMR (270 MHz, CD3CN, 25 °C,
TMS) δ = 8.00 (1 H, d, 3J (H,H) = 7.3, Acenap 4-H), 7.91 (1 H, d, 3J
(H,H) = 7.7, Acenap 7-H), 7.65 (1 H, d, 3J (H,H) = 7.7, Acenap 8-H),
7.60 (1 H, d, 3J (H,H) = 7.3, Acenap 3-H), 7.58−7.43 (5 H, m, Se+Ph
12−16-H), 7.23−7.12 (3 H, m, SPh 20−22-H), 6.94−6.85 (2 H, m,
SPh 19,23-H), 3.62−3.50 (4 H, m, 2 × CH2), 3.20 (3 H, s, 2J (H,Se) =
13.5, CH3). 77Se NMR (51.5 MHz, CDCl3, 25 °C, Me2Se): δ = 431
(s). 19F NMR (376.5 MHz, CD3CN, 25 °C, CCl3F): −79.87(s). MS
(ES+): m/z (%) 432.84 (100) [M+ − OTf].
[{Acenap(Br)(TePh)Me}+{CFSO3}−] (7). Compound 7 was
synthesized by the method described for 2 but with [Acenap(Br)-
(TePh)] (0.22 g, 0.50 mmol) and MeOTf (0.06 mL, 0.50 mmol). An
analytically pure sample was obtained by recrystallization from
diffusion of hexane into a dichloromethane solution of the product
(0.26 g, 88%); mp 135−137 °C. 1H NMR (270 MHz, CD3CN, 25 °C,
TMS) δ = 7.88 (1 H, d, 3J (H,H) = 7.5, Acenap 4-H), 7.87 (1 H, d, 3J
(H,H) = 7.5, Acenap 7-H), 7.74−7.66 (2 H, m, Te+Ph 12,16-H),
7.64−7.58 (1 H, m, Te+Ph 14-H), 7.57−7.44 (3 H, m, Acenap 3-H,
[{Acenap(TePh)(SPh)Me}+{CFSO3}−] (12). Compound 12 was
synthesized by the method described for 2 but with [Acenap(TePh)-
(SPh)] (0.34 g, 0.72 mmol) and MeOTf (0.08 mL, 0.72 mmol). An
analytically pure sample was obtained by recrystallization from
diffusion of hexane into a dichloromethane solution of the product
(0.42 g, 87%); mp 166−168 °C. 1H NMR (270 MHz, CD3CN, 25 °C,
TMS) δ = 8.00 (1 H, d, 3J (H,H) = 7.3, Acenap 4-H), 7.86 (1 H, d, 3J
(H,H) = 7.5, Acenap 7-H), 7.66−7.57 (4 H, m, Acenap 3,8-H, Te+Ph
13,15-H), 7.57−7.51 (1 H, m, Te+Ph 14-H), 7.50−7.41(2 H, m, Te+Ph
12,16-H), 7.32−7.17 (3 H, m, SPh 20−22-H), 6.96−6.87 (2 H, m, SPh
3
Te+Ph 13,15-H), 7.37 (1 H, d, J (H,H) = 7.5, Acenap 8-H), 3.52−
3.44 (2 H, m, CH2), 3.44−3.34 (2 H, m, CH2), 2.86 (3 H, s, 2J (H,Te)
= 30.6, CH3). 125Te NMR (81.2 MHz, CD3CN, 25 °C, PhTeTePh): δ
= 693. 19F NMR (376.5 MHz, CD3CN, 25 °C, CCl3F): −79.80(s).
MS (ES+): m/z (%) 452.77 (100) [M+ − OTf]. Anal. Calcd for
C20H16BrF3O3STe: C, 39.9; H, 2.7. Found: C, 40.1; H, 2.6.
2
19,23-H), 3.62−3.49 (4 H, m, 2 × CH2), 2.66 (3 H, s, J (H,Te) =
31.5, CH3). 125Te NMR (81.2 MHz, CD3CN, 25 °C, PhTeTePh): δ =
694(s). 19F NMR (376.5 MHz, CD3CN, 25 °C, CCl3F): −79.78(s).
MS (ES+): m/z (%) 482.86 (100) [M+ − OTf]. Anal. Calcd for
C26H21F3O3S2Te: C, 49.6; H, 3.4. Found: C, 49.3; H, 3.1.
[{Acenap(SPh)2Me}+{CFSO3}−] (8). Compound 8 was synthesized
by the method described for 2 but with [Acenap(SPh)2] (0.25 g, 0.69
mmol) and MeOTf (0.08 mL, 0.69 mmol). An analytically pure
sample was obtained by recrystallization from diffusion of hexane into
a dichloromethane solution of the product (0.34 g, 92%); mp 107−
109 °C. 1H NMR (270 MHz, CD3CN, 25 °C, TMS) δ = 8.05 (1 H, d,
3J (H,H) = 7.3, Acenap 4-H), 7.95 (1 H, d, 3J (H,H) = 7.7, Acenap 7-
H), 7.69−7.60 (3 H, m, Acenap 3,8-H, S+Ph 14-H), 7.60−7.43 (4 H,
m, S+Ph 12,13,15,16-H), 7.29−7.13 (3 H, m, SPh 20−22-H), 6.95−
6.85 (2 H, m, SPh 19,23-H), 3.62−3.51 (4 H, m, 2 × CH2), 3.47 (3 H,
s, CH3). 19F NMR (376.5 MHz, CD3CN, 25 °C, CCl3F): −79.81(s).
MS (ES+): m/z (%) 384.95 (100) [M+ − OTf]. Anal. Calcd for
C26H21F3O3S3: C, 58.4; H, 3.9. Found: C, 58.4; H, 3.8.
[{Acenap(TePh)(SePh)Me}+{CFSO3}−] (13). Compound 13 was
synthesized by the method described for 2 but with [Acenap(TePh)-
(SePh)] (0.10 g, 0.20 mmol) and MeOTf (0.03 mL, 0.20 mmol). An
analytically pure sample was obtained by recrystallization from
diffusion of hexane into a dichloromethane solution of the product
(0.12 g, 92%); mp 138−140 °C. 1H NMR (270 MHz, CD3CN, 25 °C,
TMS) δ = 8.13 (1 H, d, 3J (H,H) = 7.2, Acenap 4-H), 7.87 (1 H, d, 3J
(H,H) = 7.5, Acenap 7-H), 7.65−7.50 (5 H, m, Acenap 3,8-H, Te+Ph
12,14,16-H), 7.50−7.39 (2 H, m, Te+Ph 13,15-H), 7.27−7.16 (3 H, m,
SePh 20−22-H), 7.08−6.98 (2 H, m, SePh 19,23-H), 3.61−3.48 (4 H,
[{Acenap(SePh)2Me}+{CFSO3}−] (9). Compound 9 was synthe-
sized by the method described for 2 but with [Acenap(SePh)2] (0.65
g, 1.39 mmol) and MeOTf (0.16 mL, 1.39 mmol). An analytically pure
sample was obtained by recrystallization from diffusion of hexane into
a dichloromethane solution of the product (0.80 g, 91%); mp 125−
127 °C. 1H NMR (270 MHz, CD3CN, 25 °C, TMS) δ = 8.12 (1 H, d,
3J (H,H) = 7.3, Acenap 4-H), 7.91 (1 H, d, 3J (H,H) = 7.7, Acenap 7-
2
m, 2 × CH2), 2.66 (3 H, s, J (H,Te) = 32.2, CH3); 77Se NMR (51.5
4
MHz, CD3CN, 25 °C, Me2Se): δ = 323(s, J (Se,Te) = 382). 125Te
NMR (81.2 MHz, CD3CN, 25 °C, PhTeTePh): δ = 679(s, 4J
(
125Te,Se) = 382). 19F NMR (376.5 MHz, CD3CN, 25 °C, CCl3F):
−79.85(s). MS (ES+): m/z (%) 528.83 (100) [M+ − OTf]. Anal.
Calcd for C26H21F3O3SSeTe: C, 46.12; H, 3.13. Found: C, 46.25; H,
2.68.
H), 7.62 (1 H, d, J (H,H) = 7.7, Acenap 8-H), 7.60−7.44 (6 H, m,
[{Acenap(TePh)2Me2}2+{CFSO3}22−] (14). Compound 14 was
synthesized by the method described for 2 but with [Acenap(TePh)2]
(0.28 g, 0.49 mmol) and MeOTf (0.22 mL, 1.97 mmol). An
analytically pure sample was obtained by recrystallization from
diffusion of hexane into a dichloromethane solution of the product
(0.24 g, 54%); mp 115−117 °C. 1H NMR (270 MHz, CD3CN, 25 °C,
TMS) δ = 8.03−7.95 (2 H, m, Acenap 4,7-H), 7.54−7.48 (2 H, m,
Acenap 3,8-H), 7.48−7.27 (10 H, m, Te+Ph 12−16,19−23-H), 3.44 (4
H, s, 2 × CH2), 3.02 (3 H, s, 2J (H,Te) = 26.5, CH3), 2.88 (3 H, s, 2J
(H,Te) = 26.7, CH3). 125Te NMR (81.2 MHz, CD3CN, 25 °C,
PhTeTePh): δ = 677(s). 19F NMR (376.5 MHz, CD3CN, 25 °C,
CCl3F): −79.84(s). MS (ES+): m/z (%) 740.71 (95) [M+ − OTf].
Anal. Calcd for C28H24F6O6S2Te2: C, 37.6; H, 2.7. Found: C, 37.6; H,
2.8.
3
Acenap 3-H, Se+Ph 12−16-H), 7.22−7.11 (3 H, m, SePh 20−22-H),
7.07−6.97 (2 H, m, SePh 19,23-H), 3.58−3.47 (4 H, m, 2 × CH2),
3.24 (3 H, s, 2J (H,Se) = 13.6, CH3). 77Se NMR (51.5 MHz, CD3CN,
4
4
25 °C, Me2Se): δ = 422 (s, J (Se,Se) = 141), 366 (s, J (Se,Se) =
141). 19F NMR (376.5 MHz, CD3CN, 25 °C, CCl3F): −79.74(s). MS
(ES+): m/z (%) 480.84 (100) [M+ − OTf]. Anal. Calcd for
C26H21F3O3SSe2: C, 49.7; H, 3.4. Found: C, 49.5; H, 3.3.
[{Acenap(TePh)2Me}+{CFSO3}−] (10). Compound 10 was synthe-
sized by the method described for 2 but with [Acenap(TePh)2] (0.24
g, 0.42 mmol) and MeOTf (0.05 mL, 0.42 mmol). An analytically pure
sample was obtained by recrystallization from diffusion of hexane into
a dichloromethane solution of the product (0.29 g, 95%); mp 155−
157 °C. 1H NMR (270 MHz, CD3CN, 25 °C, TMS) δ = 8.47 (1 H, d,
3J (H,H) = 7.1, Acenap 4-H), 7.91 (1 H, d, 3J (H,H) = 7.5, Acenap 7-
H), 7.65−7.58 (2 H, m, Te+Ph 12,16-H), 7.58−7.51 (2 H, m, Acenap
8-H, Te+Ph 14-H), 7.51−7.39 (3 H, m, Acenap 3-H, Te+Ph 13,15-H),
7.27−7.18 (3 H, m, TePh 20−22-H), 7.18−7.10 (2 H, m, TePh 19,23-
Solid-State NMR Experimental Details. Solid-state NMR
experiments were performed using a Bruker Avance III spectrometer
operating at a magnetic field strength of 9.4 T. Experiments were
carried out using a Bruker 4-mm probe at MAS rates of between 4 and
14 kHz (77Se and 125Te) and 12.5 kHz (13C). 77Se chemical shifts are
referenced to (CH3)2Se using the resonance of Na2SeO4 at 1058.7
ppm as a secondary reference. 125Te chemical shifts are references
relative to (CH3)2Te using the resonance of Te(OH)6 (site 1) at 692.2
ppm as a secondary reference. 13C chemical shifts are referenced
relative to tetramethylsilane using the CH3 resonance of L-alanine at
20.5 ppm as a secondary reference. Transverse magnetization was
2
H), 3.60−3.47 (4 H, m, 2 × CH2), 2.70 (3 H, s, J (H,Te) = 33.1,
CH3). 125Te NMR (81.2 MHz, CD3CN, 25 °C, PhTeTePh): δ =
641(s, 4J (125Te,125Te) 946), 522(s, 4J (Te,Te) 946). 19F NMR (376.5
MHz, CD3CN, 25 °C, CCl3F): −79.77(s). MS (ES+): m/z (%) 576.78
(100) [M+ − OTf]. Anal. Calcd for C26H21F3O3STe2: C, 42.7; H, 2.9.
Found: C, 42.8; H, 2.9.
[{Acenap(SePh)(SPh)Me}+{CFSO3}−] (11). Compound 11 was
synthesized by the method described for 2 but with [Acenap(SePh)-
(SPh)] (0.25 g, 0.60 mmol) and MeOTf (0.07 mL, 0.60 mmol). An
1
obtained by cross-polarization from H using optimized contact pulse
durations of 10−15 ms (77Se), 6−12 ms (125Te), and 1−3 ms (13C).
11095
dx.doi.org/10.1021/ic301627y | Inorg. Chem. 2012, 51, 11087−11097